UK Reveals Plan To Improve Access To Safe New Medicines
Ideas Include Reduced Regulatory Burden, Working With HTA Bodies
Executive Summary
The three-year Delivery Plan just unveiled by the UK medicines agency is part of its aim to create a “new era” in drug regulation.
You may also be interested in...
UK Promises RWD Guidance In Plan To Boost Trial Innovation
The UK medicines regulator has published a new plan to deliver on several short-term projects as it tries to keep pace with the fast-moving life sciences sector and the needs of patients.
How To Navigate Northern Ireland's Complex Regulatory Landscape
A TOPRA webinar gave UK-based pharma firms an idea of the complexities and uncertainties they will need to deal with when placing medicines on the market in different parts of the UK.
Stakeholders To Have Say On Future Medicines Verification System In UK
The UK government says it will begin a consultation on a future falsified medicines scheme for Great Britain within a year after the passage of new legislation on medicines and medical devices. Moves are also under way to ensure the smooth supply of medicines from GB to Cyprus, Ireland, Malta and Northern Ireland.